Gallbladder carcinoma: the role of p53 protein overexpression and Ki‐67 antigen expression as prognostic markers

Authors:

Abstract
Gallbladder carcinoma is a relatively uncommon disease, accounting for about 0.3–0.7% of all cancer cases and having a peak incidence among women aged between 70 and 79 years [ 1 x 1 Albores‐Saavedra, J. and Henson, D.E. Tumors of the gallbladder and extrahepatic bile ducts. Atlas of Tumor Pathology, 2nd series. Fascicle 22. Armed Forces Institute of Pathology (AFIP), ; 1984 Google Scholar See all References 1 ]. The prognosis is poor, related to diagnostic delay and biological behaviour of the tumour [ 2 x 2 Diamantis, I., Karamitopoulou, E., Perentes, E., and Zimmermann, A. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Hepatology. 1995; 22: 774–779 Crossref | PubMed | Google Scholar See all References 2 ]. The pathogenic mechanisms of gallbladder carcinoma are only partially known, but genetic and environmental risk factors have been identified [ 1 x 1 Albores‐Saavedra, J. and Henson, D.E. Tumors of the gallbladder and extrahepatic bile ducts. Atlas of Tumor Pathology, 2nd series. Fascicle 22. Armed Forces Institute of Pathology (AFIP), ; 1984 Google Scholar See all References 1 , 3 x 3 Abi‐Rached, B. and Neugut, A. Diagnostic and management issues in gallbladder carcinoma. Oncology. 1995; 9: 19–30 PubMed | Google Scholar See all References 3 ].